股票 › PBLS
Parabilis医药 PBLS
美股市值排名 #2353
$28.53 +$0.65 (+2.33%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $28.53 0.00%
开盘$27.88
昨收$27.88
当日区间$27.11 – $28.87
成交量629.3K
市值$3.52B
市盈率（TTM）–
股息率–
PBLS 相关新闻
匹配 Parabilis Medicines 或代码 PBLS 的头条新闻，按最新排序。
- Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Parabilis Medicines, Inc. (PBLS) and Acumen Pharmaceuticals (ABOS)
- BofA Securities Maintains Parabilis Medicines(PBLS.US) With Buy Rating, Announces Target Price $45
- Guggenheim Sticks to Its Buy Rating for Parabilis Medicines, Inc. (PBLS)
- Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Celcuity (CELC) and Parabilis Medicines, Inc. (PBLS)
- Analysts Are Bullish on Top Healthcare Stocks: Parabilis Medicines, Inc. (PBLS), Cormedix (CRMD) 正面
- LifeSci Capital Maintains Parabilis Medicines(PBLS.US) With Buy Rating, Maintains Target Price $42
- BofA Securities Maintains Parabilis Medicines(PBLS.US) With Buy Rating
- A Quick Look at Today's Ratings for Parabilis Medicines(PBLS.US), With a Forecast Between $40 to $45
- Analysts Offer Insights on Healthcare Companies: Parabilis Medicines, Inc. (PBLS) and LENZ Therapeutics (LENZ)
- LifeSci Capital Initiates Parabilis Medicines(PBLS.US) With Buy Rating, Announces Target Price $42
- Parabilis Medicines, Inc. (PBLS) Receives a Buy From LifeSci Capital
- H.C. Wainwright Maintains Parabilis Medicines(PBLS.US) With Buy Rating, Maintains Target Price $40
- Evercore Maintains Parabilis Medicines(PBLS.US) With Buy Rating
- BofA Securities Maintains Parabilis Medicines(PBLS.US) With Buy Rating, Maintains Target Price $45
- H.C. Wainwright Initiates Parabilis Medicines(PBLS.US) With Buy Rating, Announces Target Price $40
暂无评论——快来第一个聊聊 PBLS。
登录后参与讨论。